Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the effects of vicadrostat combined with empagliflozin in adults who have type 2 diabetes, high blood pressure, and established cardiovascular disease but no history of heart failure. This study aims to understand if this combination can reduce the risk of cardiovascular events compared to a placebo combined with empagliflozin. Participation is randomized and double-blinded to compare these treatments fairly. Participants are randomly assigned to one of two groups one takes vicadrostat plus empagliflozin, and the other takes placebo tablets that look like vicadrostat plus empagliflozin. They take one tablet daily for a period ranging from two and a half years up to four years and three months. All participants continue their regular medications for diabetes, hypertension, and cardiovascular disease alongside the study treatments. Throughout the study, participants attend regular visits where their health is carefully monitored. Doctors collect information about cardiovascular events and take blood samples. They also track any side effects and changes in blood pressure and kidney function. The main outcome is the time until the first cardiovascular death or heart failure event, observed over up to 51 months. Participants stay in the study for up to four years and three months with ongoing health assessments.
Actively Recruiting
Researchers are studying children with severe anterior crowding of the upper front teeth to compare early treatment during mixed dentition with later treatment in permanent dentition. This trial aims to find out if early maxillary expansion reduces crowding after five years, improves oral health-related quality of life, causes lower dental arch adaptation, and is more cost-effective than later treatment. Children aged 6 to 9 with at least 6 millimeters of crowding and lateral incisors not fully erupted are eligible. Children in the experimental group receive a maxillary expansion device attached to specific baby teeth, which parents activate daily or every other day to create space for erupting teeth. The expansion may pause to allow spontaneous adjustment. The device is kept as a retainer until lateral incisors fully erupt. The control group receives no treatment during the observation period. Both groups attend follow-up visits over about five years, including questionnaires on pain, discomfort, and oral health quality of life. Participants undergo measurements using digital models and scans to assess changes in tooth alignment, arch width, and palatal volume. Questionnaires and cost analyses are completed to evaluate treatment impact and cost-effectiveness. Follow-ups occur at 24, 36, and 48 months, and after all permanent premolars erupt. The study measures include long-term tooth alignment, quality of life, morphological changes, complications, and costs over the five-year period.